Quantcast

Latest Thyroid neoplasm Stories

2008-07-28 06:00:25

Exelixis, Inc. (Nasdaq:EXEL) today announced that it has notified GlaxoSmithKline (GSK) that it has achieved proof-of-concept for XL184 under the collaboration agreement between GSK and Exelixis, and has submitted the corresponding data report to GSK.

2008-07-27 12:00:20

By Megan Williams, The Free Lance-Star, Fredericksburg, Va. Jul. 27--When Anita Kaissi found herself feeling constantly sluggish, she thought it was because she had just had a baby.

2008-07-22 12:00:21

San Francisco-based biotech Exelixis has seen its shares rise after taking an investigational thyroid cancer drug into a Phase III trial.

2008-07-21 12:01:26

Exelixis has initiated the Phase III registration trial of XL184 as a potential treatment for medullary thyroid cancer.

2008-07-21 06:00:17

Exelixis, Inc. (Nasdaq:EXEL) announced today that the phase 3 registration trial of XL184 as a potential treatment for medullary thyroid cancer (MTC) has been initiated. XL184 is a small molecule anticancer compound targeting the MET, RET, and VEGFR2 receptor tyrosine kinases.

2008-07-17 03:00:12

WALTHAM, Mass., July 17, 2008 (PRIME NEWSWIRE) -- OXiGENE, Inc.

2008-06-25 03:01:46

By Fisher, Ronald E Siegel, Barry A; Edell, Steven L; Oyesiku, Nelson M; Morgenstern, David E; Messmann, Richard A; Amato, Robert J ^sup 99m^Tc-EC20 is a folate receptor (FR)-targeted imaging agent consisting of the vitamin folate conjugated to ^sup 99m^Tc.

2008-06-16 06:00:07

SOUTH SAN FRANCISCO, Calif., June 16 /PRNewswire-FirstCall/ -- Exelixis, Inc. announced today that the company and the U.S.

248ba151cd92db3c1357ba18d4b825b91
2008-02-15 04:25:00

A new European study published this week surmises that weight gain increases the risk of developing most types of cancer.

2008-01-29 03:00:09

By Delikoukos, Stylianos Mantzos, Fotios Isolated thyroid gland injury due to blunt neck trauma is uncommon and rarely complicated by thyroid storm in patients without known hyperthyroidism.


Word of the Day
quotha
  • Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.
The word 'quotha' is an alteration of 'quoth he'.
Related